Clinical Trial Update: Single Lipiflow Treatment to Reduce Pharmacologic Burden in DED [NA]

View source ↗

Summary

A clinical trial update indicates enrollment by invitation for a LipiFlow treatment study aimed at reducing pharmacologic burden in dry eye disease associated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Meibomian Gland Dysfunction

Drugs mentioned

• LipiFlow

Snippet

Sponsor: Dunes Eye Consultants | Conditions: MGD-Meibomian Gland Dysfunction | NA | Status: ENROLLING_BY_INVITATION